Currently, pharmaceutical companies assemble their own in-house databases of pharmacological and physicochemical data resources. Open PHACTS integrates data from multiple publicly-available databases, giving you access to a vast linked data resource through a stable, integrated infrastructure.
This allows researchers to build better analysis pipelines — and gives researchers in academia and smaller companies unprecedented access to pharmacological data resources.
What do we mean by “linked data”?
Pharmacological entities — compounds, target pathways, etc. — each have multiple different identifiers used by different data providers. This makes finding information about an entity a complicated, fragmented process. For example, Sorafenib has the following identifiers: